Corlopam (Hospira, Inc.)
Welcome to the PulseAid listing for the Corlopam drug offered from Hospira, Inc.. This Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | FENOLDOPAM MESYLATE |
SUBSTANCE NAME: | FENOLDOPAM MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-02-28 |
END MARKETING DATE: | 0000-00-00 |
Corlopam HUMAN PRESCRIPTION DRUG Details:
Item Description | Corlopam from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2005-02-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-2304_eb239f60-ec8e-42f6-8211-90cefadba174 |
PRODUCT NDC: | 0409-2304 |
APPLICATION NUMBER: | NDA019922 |
Other FENOLDOPAM MESYLATE Pharmaceutical Manufacturers / Labelers: